Atlas Trials

Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)

Clinical trial NCT01121705 · COMPLETED

Trial details

NCT number
NCT01121705
Sponsor
Casa Sollievo della Sofferenza IRCCS
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Hepatitis
Start date
2007-01-01
Primary completion
2009-06-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.